Zonisamide Articles
Eisai epilepsy drug delayed by US FDA, but Zonegran use extension filing accepted in EU
1 August 2011
Elan pays $206 million to settle with US DoJ over past Zonegran sales and marketing activities
17 December 2010
Elan to settle over past Zonegran marketing activities in USA, with potential $203.5 million fine
19 July 2010
Japan stock market week to March 16, 2009
23 March 2009
Four Novartis drugs and B-MS
9 March 2009
Japan stock market week to Dec 3, 2007
10 December 2007
Eisai: new marketing subsidiary in Belgium
8 October 2007
Eisai's Inovelon approved for LGS in EU
29 January 2007
Japan stock market week to Nov 27, 2006
4 December 2006
OREXIGEN completes $30M financing
27 November 2006
Elan's 3rd-quarter 2006 loss widens 74%
6 November 2006
Tysabri narrows Elan's 2nd-qtr losses 37%
7 August 2006
Dr Reddy's boosted by acquisitions
12 June 2006
Elan subpoenaed over Zonegran marketing
3 April 2006
Japan stock market week to March 20, 2006
27 March 2006
Apotex gets final OK for zonisamide capsules
9 January 2006
Aricept and Aciphex lead Eisai's growth
15 August 2005
Japan stock market week to July 25
1 August 2005
Japan stock market week to July 18
25 July 2005
Japan stock market week to July 4
11 July 2005
Swiss subsid for Eisai
20 June 2005
Japan stock market week to June 10
20 June 2005
Aricept and Aciphex boost Eisai results
6 June 2005
Japan stock market week to April 4
11 April 2005
Japan stock market week to March 21
28 March 2005
Japan's Eisai sets up Italian subsidiary
7 March 2005
Japan stock market week to February 28
7 March 2005
Aricept boosts Eisai's nine month results
28 February 2005
Eisai signs deal with Cardinal for US sales
7 February 2005
Eisai moves to ensure US drug availability
24 January 2005
Japan stock market week to January 17
24 January 2005
Japan stock market three weeks to January 3
10 January 2005
Tokyo pharma stocks - week to October 18
25 October 2004
1st-qtr turnover rises 5.2% at Eisai
9 August 2004
Eisai launches new US CNS sales force
9 August 2004
Overseas sales boost Eisai's results
31 May 2004
Tokyo pharma stocks - week to April 26
3 May 2004
Tokyo pharma stocks - week to April 5
12 April 2004
Elan reports 34% drop in 2003 turnover
23 February 2004
Tokyo pharma stocks - week to Jan 26
2 February 2004
Elan gains $89.5M from Xcel investment
7 April 2003
Elan recovery plan on track to settle debts
10 February 2003
Strong earnings growth for Ireland's Elan on healthy US sales
11 February 2002
Elan net income leaps 89% in 1st qtr
24 April 2001
Draxis files Zonegran NDS in Canada
8 February 2001
Elan full-year 2000 sales top $1.50 billion
29 January 2001
Liposome and Segix boost Elan revenues
21 July 2000
Elan "on track" with key products
20 June 2000
Stock Commentary Tokyo
4 May 2000
Elan posts strong 1st quarter results
28 April 2000
Dainippon, Azwell to co-market Mystan
14 April 2000
Elan Corp gains approval of Zonegran in USA for epilepsy
29 March 2000
Elan reacquires generic nifedipine product
28 April 1999
Elan files PLA for NeuroBloc in USA
12 January 1999
Elan's Combi Nicotine Patch A Partial Success
24 November 1998
Elan Posts Record Growth In 1st Quarter 1998
27 April 1998
Stock Commentary Tokyo
8 April 1998
Stock Commentary Tokyo
26 March 1998
Elan's Zonisamide Nears US Approval
25 March 1998
Epilepsy Market Sees Strong Growth
29 July 1997
Elan Licenses Zonisamide To Dainippon
19 May 1997
THE DAWN OF A NEW ERA FOR EPILEPSY
27 September 1993
NEW HOPES FOR EPILEPSY TREATMENT
12 July 1993
DAINIPPON LICENSING
3 May 1993
DAINIPPON SETS UP US SUBSIDIARY
1 February 1993
Dainippon phase III trials
6 July 1992
DAINIPPON STARTS US ZONISAMIDE TRIALS
4 May 1992
Showing 1-83 of 83 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
